May 22, 2026
9 minutes read China’s head and neck cancer treatment has reached globally leading levels in multiple subspecialties: Nasopharyngeal cancer (NPC)…
阅读更多 →
May 22, 2026
9 minutes read China is the country with the largest cervical cancer burden globally — accounting for 23% of global…
阅读更多 →
May 22, 2026
8 minutes read Multiple Primary Cancers (MPC) — the occurrence of two or more independent primary tumors in the same…
阅读更多 →
May 22, 2026
10 minutes read Relapsed and refractory (r/r) hematologic malignancies — hematologic cancers that have progressed despite first-line treatment or remain…
阅读更多 →
May 22, 2026
10 minutes read Pediatric oncology has been among China’s most rapidly advancing fields in the past 20 years — the…
阅读更多 →
May 22, 2026
10 minutes read Over the past decade, China has emerged as one of the world’s primary developers of oncology targeted…
阅读更多 →
May 22, 2026
10 minutes read Rare cancers (such as sarcomas, neuroendocrine tumors, GIST, mesothelioma, thymoma, and rare pediatric cancers) are among the…
阅读更多 →
May 22, 2026
10 minutes read Complex oncology surgery is one of the core scenarios that brings international patients to China — China…
阅读更多 →
May 22, 2026
11 minutes read China is the only country in the world with HSCT volume on par with the United States…
阅读更多 →
